These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33260050)

  • 1. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.
    Rajan A; Nadhan R; Latha NR; Krishnan N; Warrier AV; Srinivas P
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188482. PubMed ID: 33260050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers.
    Rajan A; Varghese GR; Yadev I; Anandan J; Latha NR; Patra D; Krishnan N; Kuppusamy K; Warrier AV; Bhushan S; Nadhan R; Ram Kumar RM; Srinivas P
    Am J Cancer Res; 2022; 12(1):17-47. PubMed ID: 35141003
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lips EH; Debipersad RD; Scheerman CE; Mulder L; Sonke GS; van der Kolk LE; Wesseling J; Hogervorst FB; Nederlof PM
    Clin Cancer Res; 2017 Mar; 23(5):1236-1241. PubMed ID: 27620280
    [No Abstract]   [Full Text] [Related]  

  • 4. Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens.
    Suba Z
    Recent Pat Anticancer Drug Discov; 2017; 12(2):136-147. PubMed ID: 28245776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes.
    Sasanuma H; Tsuda M; Morimoto S; Saha LK; Rahman MM; Kiyooka Y; Fujiike H; Cherniack AD; Itou J; Callen Moreu E; Toi M; Nakada S; Tanaka H; Tsutsui K; Yamada S; Nussenzweig A; Takeda S
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10642-E10651. PubMed ID: 30352856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic exploitation of tumor cell defects in homologous recombination.
    Powell SN; Kachnic LA
    Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.
    Wen J; Li R; Lu Y; Shupnik MA
    Oncogene; 2009 Jan; 28(4):575-86. PubMed ID: 18997820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
    Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
    Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
    Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BRCA1 and Estrogen Receptor α Expression Regulation in Breast Cancer Cells].
    Scherbakov AM; Shestakova EA; Galeeva KE; Bogush TA
    Mol Biol (Mosk); 2019; 53(3):502-512. PubMed ID: 31184616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.
    Savage KI; Matchett KB; Barros EM; Cooper KM; Irwin GW; Gorski JJ; Orr KS; Vohhodina J; Kavanagh JN; Madden AF; Powell A; Manti L; McDade SS; Park BH; Prise KM; McIntosh SA; Salto-Tellez M; Richard DJ; Elliott CT; Harkin DP
    Cancer Res; 2014 May; 74(10):2773-2784. PubMed ID: 24638981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.
    Traphagen NA; Schwartz GN; Tau S; Roberts AM; Jiang A; Hosford SR; Marotti JD; Goen AE; Romo BA; Johnson AL; Duffy EK; Demidenko E; Heverly P; Mosesson Y; Soucy SM; Kolling F; Miller TW
    Clin Cancer Res; 2023 Sep; 29(18):3717-3728. PubMed ID: 37439680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer.
    Roldán G; Delgado L; Musé IM
    Cancer Biol Ther; 2006 May; 5(5):505-10. PubMed ID: 16582598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 regulates human mammary stem/progenitor cell fate.
    Liu S; Ginestier C; Charafe-Jauffret E; Foco H; Kleer CG; Merajver SD; Dontu G; Wicha MS
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1680-5. PubMed ID: 18230721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?
    Wang L; Di LJ
    Int J Biol Sci; 2014; 10(5):566-75. PubMed ID: 24910535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
    Nolan E; Vaillant F; Branstetter D; Pal B; Giner G; Whitehead L; Lok SW; Mann GB; ; Rohrbach K; Huang LY; Soriano R; Smyth GK; Dougall WC; Visvader JE; Lindeman GJ
    Nat Med; 2016 Aug; 22(8):933-9. PubMed ID: 27322743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.
    Graziano S; Johnston R; Deng O; Zhang J; Gonzalo S
    Oncogene; 2016 Oct; 35(41):5362-5376. PubMed ID: 27041576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.
    Ma Y; Hu C; Riegel AT; Fan S; Rosen EM
    Mol Endocrinol; 2007 Aug; 21(8):1905-23. PubMed ID: 17505062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.